title: Decreased methylene tetrahydrofolate reductase activity due to the 677C-->T mutation in families with spina bifida offspring.
abstract: Periconceptional folate intake reduces both the occurrence and recurrence risk of neural tube defects. Plasma homocysteine levels can be elevated in mothers of a child with a neural tube defect, suggesting a dysfunctional folate metabolism. Very recently we showed that a common 677C-->T mutation in the 5,10-methylene tetrahydrofolate reductase gene, causing thermolability of the enzyme, is a risk factor for spina bifida offspring. Restriction enzyme analysis of the genomic 5,10-methylene tetrahydrofolate reductase polymerase chain reaction fragment revealed a significantly higher prevalence of a +/+ genotype among spina bifida patients and their mothers. The risk for spina bifida offspring is the strongest if both the mother and her child have the mutation in the homozygous state. Enzymatic analysis showed that homozygosity for the 677C-->T mutation causes a decreased 5,10-methylene tetrahydrofolate reductase activity, resulting in elevated plasma homocysteine and red blood cell folate levels and lowered plasma folate and cysteine values. This extended study demonstrates that a nucleotide substitution in the coding region of 5,10-methylene tetrahydrofolate reductase, resulting in reduced activity and an impaired homocysteine and folate metabolism, is a genetic risk factor for spina bifida.
authors.affiliation: Department of Pediatrics, University Hospital Nijmegen, The Netherlands.
authors.forename: N M
authors.initials: NM
authors.lastname: van der Put
authors.forename: L P
authors.initials: LP
authors.lastname: van den Heuvel
authors.forename: R P
authors.initials: RP
authors.lastname: Steegers-Theunissen
authors.forename: F J
authors.initials: FJ
authors.lastname: Trijbels
authors.forename: T K
authors.initials: TK
authors.lastname: Eskes
authors.forename: E C
authors.initials: EC
authors.lastname: Mariman
authors.forename: M
authors.initials: M
authors.lastname: den Heyer
authors.forename: H J
authors.initials: HJ
authors.lastname: Blom
mesh_terms: D045103:5,10-Methylenetetrahydrofolate Reductase (FADH2); D000328:Adult; D000368:Aged; D002648:Child; D003545:Cysteine / Q000097:blood / Q000378:metabolism; D005260:Female; D005492:Folic Acid / Q000097:blood; D008040:Genetic Linkage; D005838:Genotype; D006710:Homocysteine / Q000097:blood / Q000378:metabolism; D006720:Homozygote; D006801:Humans; D008126:Lod Score; D008214:Lymphocytes / Q000201:enzymology / Q000378:metabolism; D008297:Male; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D008875:Middle Aged; D009426:Netherlands; D010088:Oxidoreductases / Q000172:deficiency / Q000235:genetics*; D017354:Point Mutation / Q000235:genetics*; D012307:Risk Factors; D016135:Spinal Dysraphism / Q000453:epidemiology / Q000378:metabolism*; D014805:Vitamin B 12 / Q000097:blood / Q000378:metabolism
chemical_list: D006710:Homocysteine; D005492:Folic Acid; D010088:Oxidoreductases; D045103:5,10-Methylenetetrahydrofolate Reductase (FADH2); D042965:Methylenetetrahydrofolate Reductase (NADPH2); D003545:Cysteine; D014805:Vitamin B 12